If 20 mg immediate-release propranolol is unavailable, what alternative dosing or medication should be used?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Alternative Dosing When 20mg IR Propranolol is Unavailable

If 20mg immediate-release propranolol tablets are unavailable, use 40mg IR propranolol tablets and split them in half, or substitute with 60mg long-acting (LA) propranolol once daily, which provides equivalent beta-blockade to 20mg IR three times daily.

Practical Substitution Options

Option 1: Split Higher Strength IR Tablets

  • Use 40mg IR propranolol tablets, split in half to achieve 20mg doses
  • Maintain the same three-times-daily dosing schedule (20mg TID)
  • This preserves the original pharmacokinetic profile

Option 2: Switch to Long-Acting Formulation

Long-acting propranolol 60mg once daily is pharmacokinetically equivalent to conventional propranolol 20mg three times daily 1. This substitution is supported by:

  • Pharmacodynamic equivalence: LA 60mg produces identical heart rate control and blood pressure effects as 20mg TID, both acutely and at steady state 1
  • Dose proportionality: The LA formulation demonstrates linear pharmacokinetics, making dose conversions predictable 1
  • Sustained beta-blockade: Maintains therapeutic effect throughout 24 hours without the peaks and troughs of IR formulations 2, 3

Option 3: Alternative Beta-Blockers

If propranolol is completely unavailable, consider these guideline-supported alternatives 4, 5:

For acute rate control (IV):

  • Metoprolol: 5mg IV over 1-2 minutes, repeat every 5 minutes up to 15mg total
  • Esmolol: 500 mcg/kg bolus over 1 minute, then 50-300 mcg/kg/min infusion

For oral maintenance:

  • Metoprolol tartrate: 25-100mg twice daily 6, 7
  • Atenolol: 25-100mg once daily 6, 7
  • Nadolol: 40-120mg once daily 6, 7

Important Dosing Considerations

When Converting to LA Formulation

  • LA propranolol has 30-50% lower bioavailability than IR formulations due to increased first-pass metabolism 2
  • Peak concentrations are significantly lower and delayed (Tmax 6-8 hours vs 1-2 hours) 1
  • Despite lower peak levels, clinical efficacy remains equivalent for hypertension and angina 3, 8

Clinical Context Matters

The appropriate substitution depends on the indication:

For hypertension 6, 7:

  • LA 60mg once daily is appropriate
  • Usual maintenance range: 120-160mg LA daily
  • Maximum: 640mg daily

For acute tachyarrhythmias 4, 9:

  • IV formulations preferred (0.5-1mg over 1 minute, up to 0.1mg/kg total)
  • Cannot substitute LA formulation for acute control
  • Use alternative IV beta-blockers if propranolol IV unavailable

For angina pectoris 5, 10:

  • LA 60mg once daily starting dose
  • Titrate to 160mg daily (average optimal dose)
  • Maximum studied dose: 320mg daily

Critical Safety Points

Contraindications Apply to All Formulations 4, 5

  • Avoid in asthma/reactive airway disease
  • Avoid in decompensated heart failure
  • Avoid in AV block >1st degree without pacemaker
  • Avoid in pre-excited atrial fibrillation

Monitoring Requirements

  • When initiating or increasing doses: Check heart rate and blood pressure
  • Target resting heart rate: 50-60 bpm 10
  • Watch for hypotension, bradycardia, bronchospasm

Special Populations

Renal impairment: Propranolol is hepatically metabolized, but consider dose reduction in severe renal dysfunction 6

Never abruptly discontinue: Taper gradually over several weeks to avoid rebound hypertension or angina 6, 7

Common Pitfall to Avoid

Do not assume mg-for-mg equivalence between IR and LA formulations 11. While 60mg LA ≈ 60mg total daily IR (20mg TID), the extended-release kinetics require retitration to ensure adequate 24-hour coverage, particularly for end-of-dosing-interval effectiveness.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.